Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
DaiDaiDaiBit: Currently holding only BTC and ETH, believes that the clearing of altcoins is not yet complete.

DaiDaiDaiBit: Currently holding only BTC and ETH, believes that the clearing of altcoins is not yet complete.

Odaily星球日报Odaily星球日报2026/04/17 15:26
Show original

Odaily reported that trader 带带带比特 stated that he currently mainly holds BTC and ETH, with relatively low participation in other mainstream and large-market-cap altcoin assets.

He believes that altcoin assets as a whole have not yet fully cleared out, and the market continues to show a divergence trend. The performance gap between Bitcoin and other assets is obvious. Meanwhile, he said he only participates in some gains during periodic hot topics, and maintains a cautious attitude towards low-market-cap tokens.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11